Ponatinib hydrochloride
| Ponatinib hydrochloride | |
|---|---|
| Term | Ponatinib hydrochloride |
| Short definition | ponatinib hydrochloride - (pronounced) (poh-NA-tih-nib HY-droh-KLOR-ide) drug used to treat adults with certain types of chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia. It is used in patients whose cancer has the T315I mutation or whose cancer cannot be treated with other tyrosine kinase inhibitors. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
ponatinib hydrochloride - (pronounced) (poh-NA-tih-nib HY-droh-KLOR-ide) drug used to treat adults with certain types of chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia. It is used in patients whose cancer has the T315I mutation or whose cancer cannot be treated with other tyrosine kinase inhibitors. It is also being studied in the treatment of other types of cancer. Ponatinib hydrochloride blocks BCR-ABL and other proteins that can help prevent cancer cells from growing and kill them. It can also prevent the growth of new blood vessels that tumors need to grow. Ponatinib hydrochloride is a type of tyrosine kinase inhibitor and a type of antiangiogenesis drug. Also called Iclusig
External links
- Medical encyclopedia article on Ponatinib hydrochloride
- Wikipedia's article - Ponatinib hydrochloride
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski